International Patent: MESOTHELIN-TARGETED CAR T CELLS WITH INCREASED ANTI-TUMOR EFFICACY, PERSISTENCE AND RESILIENCE AND USE THEREOF FOR THE TREATMENT OF MESOTHELIN-POSITIVE CANCERS

GENEVA, July 1 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES filed a patent application (US2025/058898) for “MESOTHELIN-TARGETED CAR T CELLS WITH INCREASED ANTI-TUMOR EFFICACY, PERSISTENCE AND RESILIENCE AND USE THEREOF FOR THE TREATMENT OF MESOTHELIN-POSITIVE CANCERS”. With publication no. WO/2026/128545, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 40/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....